CAISTOR HEALTH CENTRE — All Prescriptions & Medications — Page 4
Practice Code: C83613 | MARKET RASEN, LN7 6NX
Showing results 151-200 of 599
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Methotrexate | 220 | 5,884 | £336 | -32.4% ▼ |
| Nicorandil | 219 | 10.3K | £1.2K | +52.1% ▲ |
| Estriol | 219 | 3,459 | £3.7K | +2.9% ▲ |
| Insulin glargine | 217 | 1,102 | £7.6K | -23.6% ▼ |
| 213 | 42.3K | £988 | -19.3% ▼ | |
| Lorazepam | 212 | 7,483 | £2.3K | +48.7% ▲ |
| Letrozole | 207 | 5,796 | £530 | +10.9% ▲ |
| Cefalexin | 202 | 6,803 | £501 | +73.7% ▲ |
| Sacubitril/valsartan | 201 | 10.1K | £16.0K | -16.1% ▼ |
| Memantine hydrochloride | 200 | 5,348 | £815 | -39.5% ▼ |
| Naftidrofuryl oxalate | 198 | 18.5K | £2.1K | +507.7% ▲ |
| Methylphenidate hydrochloride | 193 | 7,840 | £4.6K | -25.3% ▼ |
| Lymecycline | 193 | 6,097 | £733 | +60.5% ▲ |
| Pivmecillinam hydrochloride | 192 | 1,970 | £1.0K | +265.7% ▲ |
| Ferrous gluconate | 190 | 5,880 | £179 | +297.3% ▲ |
| Carbamazepine | 186 | 8,176 | £652 | -37.3% ▼ |
| Enalapril maleate | 185 | 8,085 | £1.0K | +3.0% ▲ |
| 185 | 28.8K | £1.1K | -33.1% ▼ | |
| Docusate sodium | 182 | 17.6K | £1.1K | -50.9% ▼ |
| Fluticasone/umeclidinium/vilanterol | 179 | 182 | £7.5K | -23.6% ▼ |
| Calcipotriol | 177 | 13.1K | £6.7K | +4.0% ▲ |
| Topiramate | 176 | 13.3K | £2.1K | -1.0% vs avg |
| Sodium valproate | 176 | 31.0K | £3.9K | -44.7% ▼ |
| Dexamethasone | 176 | 925 | £562 | +2.4% ▲ |
| Cyanocobalamin | 175 | 5,083 | £420 | -50.4% ▼ |
| Tadalafil | 174 | 3,096 | £1.3K | +2.3% ▲ |
| 173 | 1,009 | £271 | +1,868.1% ▲ | |
| Peppermint oil | 168 | 6,257 | £909 | +111.1% ▲ |
| Ispaghula husk | 167 | 7,776 | £1.4K | +26.8% ▲ |
| Valproic acid | 163 | 8,370 | £1.9K | +87.3% ▲ |
| Clonazepam | 158 | 12.1K | £1.8K | +1.4% vs avg |
| 158 | 2,015 | £3.1K | +326.5% ▲ | |
| Olanzapine | 154 | 5,348 | £1.2K | -58.4% ▼ |
| Loratadine | 152 | 4,896 | £109 | -27.3% ▼ |
| Baclofen | 152 | 34.5K | £532 | -24.1% ▼ |
| Biphasic insulin aspart | 150 | 1,245 | £7.1K | +47.7% ▲ |
| Famotidine | 149 | 5,138 | £3.1K | -69.5% ▼ |
| Metoclopramide hydrochloride | 149 | 8,626 | £375 | +79.8% ▲ |
| Medroxyprogesterone acetate | 148 | 151 | £813 | +22.6% ▲ |
| Procyclidine hydrochloride | 147 | 5,900 | £229 | +3.9% ▲ |
| Bimatoprost | 146 | 3,192 | £1.6K | -1.8% vs avg |
| Irbesartan | 145 | 1,897 | £87 | -40.5% ▼ |
| Glimepiride | 143 | 6,030 | £176 | +55.0% ▲ |
| 143 | 19.9K | £997 | -33.9% ▼ | |
| Sulfasalazine | 141 | 16.7K | £4.1K | +8.3% ▲ |
| Azathioprine | 140 | 8,216 | £193 | +29.2% ▲ |
| 139 | 24.1K | £1.4K | +36.8% ▲ | |
| Paroxetine hydrochloride | 138 | 5,094 | £322 | -26.0% ▼ |
| Nifedipine | 137 | 7,987 | £2.1K | -26.9% ▼ |
| Etoricoxib | 135 | 3,338 | £623 | +67.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.